Search hospitals > Michigan > Grand Rapids
Helen DeVos Children's Hospital at Spectrum Health
Claim this profileGrand Rapids, Michigan 49503
Global Leader in Cancer
Global Leader in Neuroblastoma
Conducts research for Brain Tumor
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Solid Tumors
333 reported clinical trials
8 medical researchers
Summary
Helen DeVos Children's Hospital at Spectrum Health is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Cancer, Neuroblastoma, Brain Tumor, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Helen DeVos Children's Hospital at Spectrum Health is involved with conducting 333 clinical trials across 584 conditions. There are 8 research doctors associated with this hospital, such as Kathleen J. Yost, Troy Quigg, DO, David Hoogstra, and Deanna Mitchell, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Neuroblastoma
Global LeaderMYC positive
Stage IV
Stage I
Top PIs
Kathleen J. YostBronson Methodist Hospital8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
233 reported clinical trials
343 drugs studied
Troy Quigg, DOHelen DeVos Children's Hospital7 years of reported clinical research
Studies Metabolic disorders
Studies Severe Combined Immunodeficiency
11 reported clinical trials
30 drugs studied
David HoogstraHelen DeVos Children's Hospital1 year of reported clinical research
Studies Neuroblastoma
Studies Brain Tumor
6 reported clinical trials
12 drugs studied
Deanna Mitchell, MDHelen DeVos Children's Hospital5 years of reported clinical research
Studies Neuroblastoma
3 reported clinical trials
7 drugs studied
Clinical Trials running at Helen DeVos Children's Hospital at Spectrum Health
Lung Cancer
Multiple Myeloma
Melanoma
Acute Lymphoblastic Leukemia
Leukemia
Cutaneous Melanoma
Breast Cancer
Testicular cancer
Cancer
Pancreatic Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Helen DeVos Children's Hospital at Spectrum Health?
Helen DeVos Children's Hospital at Spectrum Health is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Cancer, Neuroblastoma, Brain Tumor, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Helen DeVos Children's Hospital at Spectrum Health is involved with conducting 333 clinical trials across 584 conditions. There are 8 research doctors associated with this hospital, such as Kathleen J. Yost, Troy Quigg, DO, David Hoogstra, and Deanna Mitchell, MD.
Where is Helen DeVos Children's Hospital at Spectrum Health located?
Helen DeVos Children's Hospital at Spectrum Health, situated in downtown Grand Rapids, Michigan, at 100 Michigan St. NE, Grand Rapids, MI 49503, is a leading freestanding children's hospital. It boasts over 300 pediatric specialists and subspecialists across more than 50 pediatric specialties and programs. The hospital is acclaimed by U.S. News & World Report as a Best Children's Hospital, highlighting its commitment to providing expert pediatric care.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance at Helen DeVos Children's Hospital:**
- For financial assistance, contact the department at 844.838.3115 to determine eligibility and explore payment options.
- Apply for assistance using the Confidential Financial Assistance Application, available in multiple languages.
- For application assistance or other inquiries, connect with a Lakeland financial counselor at 844.408.4103, available Monday through Friday, 8 a.m. to 4:30 p.m.
**Insurance Inquiries:**
- For insurance-related questions, contact Spectrum Health for Employers at 616.391..... for detailed information and support.
What insurance does Helen DeVos Children's Hospital at Spectrum Health accept?
Helen DeVos Children's Hospital at Spectrum Health accepts most commercial insurance plans, Medicare, and Medicaid. They contract with a variety of payers including Aetna, Anthem/Blue Cross Blue Shield, Cigna, Humana, UnitedHealthcare Insurance Company, and WellCare Health Plans. Financial Counselors are available to assist with determining individual plan coverage.
What awards or recognition has Helen DeVos Children's Hospital at Spectrum Health received?
Helen DeVos Children's Hospital at Spectrum Health, located in Grand Rapids, Michigan, has been recognized as a Best Children's Hospital by U.S. News & World Report and has earned Magnet Recognition status from the American Nurses Credentialing Center. The hospital's hematology, oncology, and bone marrow transplant program was awarded the American Society of Clinical Oncology Award, distinguishing it as one of only eight hospitals in the U.S. to receive this honor. This follows a successful capital campaign initiated by a $50 million gift from the children of Rich and Helen DeVos, raising a total of $103 million.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.